You are here
- Home
- Drug Products
- All Drug Products
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative, Phase 4 Study
- Disease
- bipolar mania
- Drug Name
- Seroquel XR
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Dec 14, 2010
- Study Name
- D1443L00086
- Study Id
- D1443L00086
- ClinicalTrials.gov ID
- NCT01254721
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
